Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 19, 2015 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
55
Frequently Asked Questions
What is Market Cap of Kezar Life Sciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Kezar Life Sciences Inc market cap is $28.93M.
What is the 52-week high for Kezar Life Sciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Kezar Life Sciences Inc 52 week high is $9.18 as of September 16, 2025.
What is the 52-week low for Kezar Life Sciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Kezar Life Sciences Inc 52 week low is $3.62 as of September 16, 2025.
What is Kezar Life Sciences Inc stock price today?
Kezar Life Sciences Inc stock price today is $3.91.
What was Kezar Life Sciences Inc stock price yesterday?
Kezar Life Sciences Inc stock price yesterday was $3.95.
What is the PE ratio of Kezar Life Sciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Kezar Life Sciences Inc’s P/E ratio is -0.41.
What is the Price-to-Book ratio of Kezar Life Sciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Kezar Life Sciences Inc P/B ratio is 0.3148.
What is the 50-day moving average of Kezar Life Sciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Kezar Life Sciences Inc 50-day moving average is $4.16.
How many employess does Kezar Life Sciences Inc has?